{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:36:06Z","timestamp":1791894966092,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.amjms.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:03:46Z","timestamp":1760997826000},"page":"107-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 in retrospect: Public health lessons from a global crisis"],"prefix":"10.1016","volume":"371","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8033-7521","authenticated-orcid":false,"given":"Dale W.","family":"Bratzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2025.10.008_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2025.10.008_bib0002","unstructured":"World Health Organization. Pneumonia of Unknown Cause \u2013 China. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2020-DON229 [accessed 12.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0003","first-page":"245","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev"},{"key":"10.1016\/j.amjms.2025.10.008_bib0004","series-title":"National Library of Medicine. NCBI Insights. Novel coronavirus Complete Genome from the Wuhan outbreak Now Available in GenBank","year":"2020"},{"key":"10.1016\/j.amjms.2025.10.008_bib0005","unstructured":"Centers For Disease Control and Prevention. CDC Museum COVID-19 Timeline. https:\/\/www.cdc.gov\/museum\/timeline\/covid19.html [accessed 12.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0006","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.008_bib0007","article-title":"European Centre for Disease Prevention and Control. Note from the editors: world Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern","volume":"25","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.amjms.2025.10.008_bib0008","unstructured":"Administration For Strategic Preparedness & Response. Determination that a Public Health Emergency Exists. https:\/\/aspr.hhs.gov\/legal\/PHE\/Pages\/2019-nCoV.aspx [accessed 12.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0009","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2025.10.008_bib0011","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3201\/eid2704.204576","article-title":"Analysis of asymptomatic and presymptomatic transmission in SARS-CoV-2 outbreak, Germany 2020","volume":"27","author":"Bender","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.008_bib0012","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2025.10.008_bib0013","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2025.10.008_bib0014","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.amjms.2025.10.008_bib0015","unstructured":"National Institutes of Health. NIH Clinical Trial of Investigational Vaccine For COVID-19 Begins. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-clinical-trial-investigational-vaccine-covid-19-begins [accessed 13.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0016","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.amjms.2025.10.008_bib0017","series-title":"World Health Organization. Report of the WHO-China Joint Mission On Coronavirus Disease 2019 (COVID-19). 28 February","year":"2020"},{"key":"10.1016\/j.amjms.2025.10.008_bib0018","unstructured":"World Health Organizations. Coronavirus disease 2019 (COVID-19) Situation Report \u201375. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200404-sitrep-75-covid-19.pdf [accessed 15.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0019","series-title":"Euro News. Coronavirus: Half of Humanity Now On Lockdown As 90 Countries Call For Confinement","year":"2020"},{"key":"10.1016\/j.amjms.2025.10.008_bib0020","unstructured":"EducationWeek. The Coronavirus Spring: The Historic Closing of U.S. Schools (A Timeline). https:\/\/www.edweek.org\/leadership\/the-coronavirus-spring-the-historic-closing-of-u-s-schools-a-timeline\/2020\/07 [accessed 15.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0021","unstructured":"Federal Register. No Sail Order and Suspension of Further Embarkation. https:\/\/www.federalregister.gov\/documents\/2020\/03\/24\/2020-06166\/no-sail-order-and-suspension-of-further-embarkation [accessed 18.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0022","series-title":"Pentagon Asked to Provide 85 Refrigerated trucks, 100K Body Bags For Coronavirus response. April 3","year":"2020"},{"key":"10.1016\/j.amjms.2025.10.008_bib0023","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00068-021-01717-w","article-title":"Management of mass casualties due to COVID-19 handling the dead","volume":"47","author":"Petrone","year":"2021","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1016\/j.amjms.2025.10.008_bib0024","unstructured":"Statista. Impact of the Coronavirus Pandemic On the Global Economy - Statistics & acts https:\/\/www.statista.com\/topics\/6139\/covid-19-impact-on-the-global-economy\/[accessed 08.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0025","unstructured":"International Monetary Fund. Policy responses to COVID-19. https:\/\/www.imf.org\/en\/Topics\/imf-and-covid19\/Policy-Responses-to-COVID-19 [accessed 12.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0026","unstructured":"United Nations. WHO Chief Declares End to COVID-19 As a Global Health Emergency. https:\/\/news.un.org\/en\/story\/2023\/05\/1136367 [accessed 12.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0027","doi-asserted-by":"crossref","first-page":"846","DOI":"10.15585\/mmwr.mm7023a3","article-title":"Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020\u2013May 2021","volume":"70","author":"Paul","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjms.2025.10.008_bib0028","first-page":"1267","article-title":"From Alpha to Omicron: how different variants of concern of the SARS-Coronavirus-2 impacted the world","volume":"12","author":"Andre","year":"2023","journal-title":"Biol (Basel)"},{"key":"10.1016\/j.amjms.2025.10.008_bib0029","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2025.10.008_bib0030","first-page":"270","article-title":"Changing features of COVID-19: characteristics of infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) variants in southern Italy","volume":"593","author":"Loconsole","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2025.10.008_bib0031","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study","volume":"22","author":"Twohig","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.008_bib0032","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0033","series-title":"World Health Organization. WHO Director-General\u2019s opening Remarks At the Media Briefing On COVID-19 - 14 December","year":"2021"},{"key":"10.1016\/j.amjms.2025.10.008_bib0034","unstructured":"WorldOMeter. https:\/\/www.worldometers.info\/coronavirus\/country\/us\/[accessed 27.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/v14020294","article-title":"The spread of SARS-CoV-2 variant Omicron with a doubling time of 2.0-3.3 days can be explained by immune evasion","volume":"14","author":"Grabowski","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.amjms.2025.10.008_bib0036","series-title":"Pfizer and BioNTech Provide Update on Omicron Variant. Press release On December 8","year":"2021"},{"key":"10.1016\/j.amjms.2025.10.008_bib0037","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.amjms.2025.10.008_bib0038","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2025.10.008_bib0039","unstructured":"Wikipedia. COVID-19 Vaccine. https:\/\/en.wikipedia.org\/wiki\/COVID-19_vaccine [accessed 01.08.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/15476286.2022.2055923","article-title":"Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases","volume":"19","author":"Rouf","year":"2022","journal-title":"RNA Biol"},{"key":"10.1016\/j.amjms.2025.10.008_bib0041","unstructured":"Department of Health and Human Services. Trump Administration Announces Framework and Leadership for \u2018Operation Warp Speed.\u2019 https:\/\/web.archive.org\/web\/20201216233803\/https:\/\/www.hhs.gov\/about\/news\/2020\/05\/15\/trump-administration-announces-framework-and-leadership-for-operation-warp-speed.html [accessed 01.08.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0042","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.abc5312","article-title":"A strategic approach to COVID-19 vaccine R&D","volume":"368","author":"Corey","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.amjms.2025.10.008_bib0043","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.vaccine.2012.04.060","article-title":"RNA-based vaccines","volume":"30","author":"Ulmer","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.amjms.2025.10.008_bib0044","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjms.2025.10.008_bib0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1126\/science.abi8397","article-title":"The story behind COVID-19 vaccines","volume":"372","author":"Fauci","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.amjms.2025.10.008_bib0046","first-page":"71","article-title":"Formulation and delivery technologies for mRNA vaccines","volume":"440","author":"Zeng","year":"2022","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.amjms.2025.10.008_bib0047","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0048","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0049","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/vaccines11020432","article-title":"Adenoviral vector-based vaccine platform for COVID-19: current status","volume":"11","author":"Chavda","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.amjms.2025.10.008_bib0050","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0051","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.3390\/v14122794","article-title":"Improved expression of SARS-CoV-2 spike RBD using the insect cell-Baculovirus system","volume":"14","author":"Poodts","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.amjms.2025.10.008_bib0052","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0053","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and efficacy of NVX-CoV2373 COVID-19 vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0054","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0055","series-title":"CIDRAP - Center for Infectious Disease Research & Policy. FDA Approves Full License For Novavax\u2019s COVID Vaccine","year":"2025"},{"key":"10.1016\/j.amjms.2025.10.008_bib0056","series-title":"Two Years of U.S. COVID-19 Vaccines Have Prevented millions of Hospitalizations and deaths,\u201d To the Point (blog), Commonwealth Fund","author":"Fitzpatrick","year":"2022"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.008_bib0057","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.20385","article-title":"Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US. December 2020 to September 2021","volume":"5","author":"Steele","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjms.2025.10.008_bib0058","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.008_bib0059","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.2223","article-title":"Global estimates of lives and life-years saved by COVID-19 vaccination during 2020-2024","volume":"6","author":"Ioannidis","year":"2025","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.amjms.2025.10.008_bib0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1056\/NEJMoa2116063","article-title":"COVID-19 vaccine effectiveness in New York State","volume":"386","author":"Rosenberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.008_bib0061","doi-asserted-by":"crossref","first-page":"pgac082","DOI":"10.1093\/pnasnexus\/pgac082","article-title":"Durability analysis of the highly effective BNT162b2 vaccine against COVID-19","volume":"1","author":"Puranik","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.amjms.2025.10.008_bib0062","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.15585\/mmwr.mm7034e3","volume":"70","author":"Nanduri","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.008_bib0063","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10650","article-title":"Evaluation of waning of SARS-CoV-2 vaccine\u2013induced immunity. A systematic review and meta-analysis","volume":"6","author":"Menegale","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjms.2025.10.008_bib0064","doi-asserted-by":"crossref","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","article-title":"Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status \u2014 United States, April 2021\u2013September 2022","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjms.2025.10.008_bib0065","unstructured":"COVID-19 Seroprevalence Studies Hub. https:\/\/github.com\/episphere\/serohub\/wiki [accessed 02.08.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.amjms.2025.10.008_bib0067","unstructured":"Centers For Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) Vaccine Safety. https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/covid-19.html [accessed 03.08.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0068","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.amjms.2025.10.008_bib0069","series-title":"Safety Platform for Emerging Vaccines S. D2.3 Priority list of Adverse Events of Special interest: COVID-19. Brighton Collaboration","year":"2020"},{"key":"10.1016\/j.amjms.2025.10.008_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.951314","article-title":"Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: a systematic review and meta-analysis","volume":"9","author":"Voleti","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0071","article-title":"Post-Vaccination Syndrome: a descriptive analysis of reported symptoms and patient experiences after Covid-19 immunization","author":"Krumholz","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.amjms.2025.10.008_bib0072","article-title":"Immunological and antigenic signatures associated with chronic illnesses after COVID-19 vaccination","author":"Bhattacharjee","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.amjms.2025.10.008_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110493","article-title":"Natural history of COVID-19 and current knowledge on treatment therapeutic options","volume":"129","author":"Dos Santos","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.amjms.2025.10.008_bib0074","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or moderate COVID-19","volume":"383","author":"Gandhi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0075","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.amjms.2025.10.008_bib0076","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2025.10.008_bib0077","article-title":"Antiviral agents for the treatment of COVID-19: progress and challenges","volume":"3","author":"Singh","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0078","unstructured":"Food and Drug Administration. Emergency Use Authorization of Pemgarda (Pemivibart). www.fda.gov\/media\/177067\/download [accessed 03.08.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0079","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0080","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19\u2014Final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0081","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0082","series-title":"Effectiveness of Tocilizumab, Sarilumab, and Anakinra for Critically Ill Patients With COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial","year":"2021"},{"key":"10.1016\/j.amjms.2025.10.008_bib0083","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-241105","article-title":"Steroid harms if given early in COVID-19 viraemia","volume":"14","author":"Arora","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.amjms.2025.10.008_bib0084","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijid.2023.03.030","article-title":"Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: a real-world study","volume":"131","author":"Nevola","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.008_bib0085","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570371\/pdf\/Bookshelf_NBK570371.pdf [accessed 18.07.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0086","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.2022.4877","article-title":"Systemic corticosteroid use for COVID-19 in US outpatient settings from April 2020 to August 2021","volume":"327","author":"Bradley","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.amjms.2025.10.008_bib0087","doi-asserted-by":"crossref","DOI":"10.7326\/ANNALS-24-04111","article-title":"Antibiotic, Glucocorticoid, and Opioid Prescribing in Urgent Cares: an Opportunity for Reducing Medication Overuse","author":"Cohen-Mekelburg","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0088","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijid.2020.12.048","article-title":"Pandemic preparedness and response to COVID-19 in South Asian countries","volume":"104","author":"Babu","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.008_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106263","article-title":"Contributing factors to personal protective equipment shortages during the COVID-19 pandemic","volume":"141","author":"Cohen","year":"2020","journal-title":"Prev Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4187\/respcare.10676","article-title":"COVID-19 Lessons Learned: response to the Anticipated Ventilator Shortage","volume":"68","author":"Branson","year":"2023","journal-title":"Respir Care"},{"key":"10.1016\/j.amjms.2025.10.008_bib0091","first-page":"475","article-title":"Pandemic preparedness: COVID-19 lessons learned in New York\u2019s hospitals","volume":"48","author":"Jarrett","year":"2022","journal-title":"Jt Comm J Qual Pat Safe"},{"key":"10.1016\/j.amjms.2025.10.008_bib0092","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3390\/healthcare11182572","article-title":"Pandemic preparedness: a scoping review of best and worst practices from COVID-19","volume":"11","author":"Maccaro","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.amjms.2025.10.008_bib0093","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1257\/jep.37.4.3","article-title":"Why did the best prepared country in the world fare so poorly during COVID?","volume":"37","author":"Nuzzo","year":"2023","journal-title":"J Econ Perspect"},{"key":"10.1016\/j.amjms.2025.10.008_bib0094","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMp2406427","article-title":"D\u00e9j\u00e0 vu all over again \u2014 Refusing to learn the lessons of COVID-19","volume":"391","author":"Sinha","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0095","article-title":"Are we ready for the next pandemic? Five reasons to feel confident \u2013 and five to be worried","author":"Thurston","year":"2025","journal-title":"Brink"},{"key":"10.1016\/j.amjms.2025.10.008_bib0096","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2105\/AJPH.2020.305933","article-title":"Reimagining Global Health Governance in the Age of COVID-19","volume":"110","author":"Gostin","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjms.2025.10.008_bib0097","unstructured":"Johns Hopkins Bloomberg School of Public Health. The U.S. and the WHO: An Imperfect But Essential Relationship. https:\/\/publichealth.jhu.edu\/2025\/the-consequences-of-the-us-withdrawal-from-the-who [accessed 16.08.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0098","series-title":"Issue Brief: COVID-19 and Telehealth Changes","year":"2020"},{"key":"10.1016\/j.amjms.2025.10.008_bib0099","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/jamia\/ocaa067","article-title":"Telehealth transformation: COVID-19 and the rise of virtual care","volume":"27","author":"Wosik","year":"2020","journal-title":"J Am Med Inf Assoc"},{"key":"10.1016\/j.amjms.2025.10.008_bib0100","series-title":"National Healthcare Quality and Disparities Report. Growth of Telehealthcare During the COVID-19 Pandemic","year":"2023"},{"issue":"6497","key":"10.1016\/j.amjms.2025.10.008_bib0101","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd3377","article-title":"COVID-19 and cancer","volume":"368","author":"Sharpless","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.amjms.2025.10.008_bib0102","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/jgs.17805","article-title":"Delayed medical care and its perceived health impact among US older adults during the COVID-19 pandemic","volume":"70","author":"Zhong","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjms.2025.10.008_bib0103","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1377\/hlthaff.2022.00509","article-title":"Delayed medical care and unmet care needs due to the COVID-19 pandemic among adults with disabilities in the US","volume":"41","author":"Akobirshoev","year":"2022","journal-title":"Health Aff"},{"key":"10.1016\/j.amjms.2025.10.008_bib0104","first-page":"737","article-title":"Indirect effects of the COVID-19 pandemic on well-child visits in low-income children in Oklahoma","volume":"31","author":"Beetch","year":"2025","journal-title":"J Public Health Manag Pr"},{"key":"10.1016\/j.amjms.2025.10.008_bib0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.22454\/FamMed.2022.922801","article-title":"Delays in children\u2019s preventive services during the COVID-19 pandemic","volume":"54","author":"Nguyen","year":"2022","journal-title":"Fam Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0106","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2105\/AJPH.2022.307096","article-title":"Excess mortality from non\u2013COVID-19 causes during the COVID-19 pandemic in Philadelphia, Pennsylvania, 2020\u20132021","volume":"112","author":"Todd","year":"2022","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjms.2025.10.008_bib0107","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77562","article-title":"Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022","volume":"12","author":"Lee","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.amjms.2025.10.008_bib0108","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3201\/eid2705.204523","article-title":"Racial and ethnic disparities in incidence of SARS-CoV-2 infection, 22 US States and DC, January 1-October 1, 2020","volume":"27","author":"Hollis","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.008_bib0109","doi-asserted-by":"crossref","first-page":"560","DOI":"10.15585\/mmwr.mm7015e2","article-title":"Trends in racial and ethnic disparities in COVID-19 hospitalizations, by region - United States, March-December 2020","volume":"70","author":"Romano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjms.2025.10.008_bib0110","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1377\/hlthaff.2023.00729","article-title":"Substantial disparities in COVID-19 vaccine uptake and unmet immunization demand in low- and middle-income countries","volume":"42","author":"Fox","year":"2023","journal-title":"Health Aff"},{"key":"10.1016\/j.amjms.2025.10.008_bib0111","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1213\/ANE.0000000000004846","article-title":"The COVID-19 pandemic: effects on low- and middle-income countries","volume":"131","author":"Bong","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.amjms.2025.10.008_bib0112","unstructured":"University of Mary Washington Simpson Library. Misinformation and Disinformation. https:\/\/library.umw.edu\/c.php?g=1068208&p=10484636 [accessed 17.08.25]."},{"key":"10.1016\/j.amjms.2025.10.008_bib0113","article-title":"Combating misinformation as a core function of public health","volume":"4","author":"Knudsen","year":"2023","journal-title":"NEJM Catal Innov Care Deliv"},{"key":"10.1016\/j.amjms.2025.10.008_bib0114","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.amsu.2020.10.007","article-title":"Public health prevention and emergency preparedness funding in the United States: are we ready for the next pandemic?","volume":"59","author":"Sen-Crowe","year":"2020","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.amjms.2025.10.008_bib0115","series-title":"NACCHO New Analysis: Changes in Local Health Department Workforce and Finance Capacity Since 2008","year":"2020"},{"issue":"1\u20133","key":"10.1016\/j.amjms.2025.10.008_bib0116","first-page":"e29","article-title":"The legal authority for states\u2019 stay-at-home orders","volume":"383","author":"Hall","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.008_bib0117","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/jama.2020.5460","article-title":"Governmental public health powers during the COVID-19 pandemic","volume":"323","author":"Gostin","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.amjms.2025.10.008_bib0118","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2105\/AJPH.2022.307214","article-title":"Trends in US state public health emergency laws, 2021-2022","volume":"113","author":"Platt","year":"2022","journal-title":"Am J Pub Health"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:55:58Z","timestamp":1769090158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925012480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0002962925012480"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.008","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 in retrospect: Public health lessons from a global crisis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}